Ys Biopharma Co Stock Analysis

YS Biopharma Stock Analysis Notes

About 14.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 0.29. YS Biopharma had not issued any dividends in recent years.

YS Biopharma Investment Alerts

YS Biopharma Upcoming and Recent Events

YS Biopharma SEC Filings

YS Biopharma Thematic Classifications

YS Biopharma Stock Institutional Investors

Note, although YS Biopharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

YS Biopharma Market Capitalization

The company currently falls under 'Micro-Cap' category with a market capitalization of 44.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate YS Biopharma's market, we take the total number of its shares issued and multiply it by YS Biopharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

YS Biopharma Profitablity

The company has Net Profit Margin (PM) of (0.45) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.4) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.4.

Management Efficiency

Return on Average Assets is likely to drop to -0.29 in 2023. Return on Average Equity is likely to drop to -29.34 in 2023. At this time, YS Biopharma's Total Assets are comparatively stable as compared to the past year. Assets Non Current is likely to gain to about 706.2 M in 2023, whereas Goodwill and Intangible Assets are likely to drop slightly above 75.1 M in 2023. YS Biopharma's management efficiency ratios could be used to measure how well YS Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 30th of November, YS Biopharma owns the information ratio of (0.17), and Market Risk Adjusted Performance of (4.78). Concerning fundamental indicators, the technical analysis model lets you check potential technical drivers of YS Biopharma, as well as the relationship between them. Strictly speaking, you can use this information to find out if the company will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We are able to interpolate and collect thirteen technical drivers for YS Biopharma, which can be compared to its peers in the sector. Please check out YS Biopharma standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if YS Biopharma Co is priced fairly, providing market reflects its prevailing price of 0.56 per share. As YS Biopharma is a penny stock we also advise to confirm its jensen alpha numbers.

YS Biopharma Price Movement Analysis

YS Biopharma Predictive Daily Indicators

YS Biopharma Forecast Models

YS Biopharma's time-series forecasting models are one of many YS Biopharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary YS Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how YS Biopharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling YS Biopharma shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as YS Biopharma. By using and applying YS Biopharma Stock analysis, traders can create a robust methodology for identifying YS Biopharma entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. YS Biopharma analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. YS Biopharma analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

YS Biopharma Co stock analysis indicators help investors evaluate how YS Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading YS Biopharma shares will generate the highest return on investment. By understating and applying YS Biopharma stock analysis, traders can identify YS Biopharma position entry and exit signals to maximize returns.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in YS Biopharma Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

When running YS Biopharma's price analysis, check to measure YS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy YS Biopharma is operating at the current time. Most of YS Biopharma's value examination focuses on studying past and present price action to predict the probability of YS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move YS Biopharma's price. Additionally, you may evaluate how the addition of YS Biopharma to your portfolios can decrease your overall portfolio volatility.

Is YS Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of YS Biopharma. If investors know YS Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about YS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of YS Biopharma is measured differently than its book value, which is the value of YS Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of YS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is YS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because YS Biopharma's market value can be influenced by many factors that don't directly affect YS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between YS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if YS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, YS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.